AnaptysBio, Inc. is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Daniel R. Faga, with a market cap of $1.7B.
Based on Q1 2026 filing
Common questions about AnaptysBio, Inc.
AnaptysBio, Inc. (ANAB) has a market capitalization of $1.7B and trades on NASDAQ.
AnaptysBio, Inc. has approximately 117 employees.